680 related articles for article (PubMed ID: 18988129)
1. [Long-term treatment of refractory myasthenia gravis with immunoadsorption].
Wagner S; Janzen RW; Mohs C; Pohlmann S; Klingel R; Grützmacher PW
Dtsch Med Wochenschr; 2008 Nov; 133(46):2377-82. PubMed ID: 18988129
[TBL] [Abstract][Full Text] [Related]
2. Long-term treatment of myasthenia gravis with immunoadsorption.
Haas M; Mayr N; Zeitlhofer J; Goldammer A; Derfler K
J Clin Apher; 2002; 17(2):84-7. PubMed ID: 12210711
[TBL] [Abstract][Full Text] [Related]
3. A randomized and controlled study comparing immunoadsorption and plasma exchange in myasthenic crisis.
Köhler W; Bucka C; Klingel R
J Clin Apher; 2011 Dec; 26(6):347-55. PubMed ID: 22095647
[TBL] [Abstract][Full Text] [Related]
4. [Immunoadsorption therapy for myasthenia gravis: study on the adsorption capacity of an immunoadsorption column].
Yeh JH; Chiu HC
J Microbiol Immunol Infect; 1999 Jun; 32(2):121-5. PubMed ID: 11565565
[TBL] [Abstract][Full Text] [Related]
5. Changes of plasma proteins after immunoadsorption using Ig-Adsopak columns in patients with myasthenia gravis.
Pták J
Transfus Apher Sci; 2004 Apr; 30(2):125-9. PubMed ID: 15062750
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic apheresis in myasthenia gravis.
Batocchi AP; Evoli A; Di Schino C; Tonali P
Ther Apher; 2000 Aug; 4(4):275-9. PubMed ID: 10975473
[TBL] [Abstract][Full Text] [Related]
7. Elimination of IgG subclasses of anti-acetylcholine receptor antibodies in myasthenic plasma by immunoadsorption to protein A.
Szpirt W; Somnier F; Nielsen FC; Rødgaard A
Life Support Syst; 1985; 3 Suppl 1():351-5. PubMed ID: 3916613
[No Abstract] [Full Text] [Related]
8. Long-term effects of a multimodal approach including immunoadsorption for the treatment of myasthenic crisis.
Zeitler H; Ulrich-Merzenich G; Hoffmann L; Kornblum C; Schmidt S; Vetter H; Walger P
Artif Organs; 2006 Aug; 30(8):597-605. PubMed ID: 16911313
[TBL] [Abstract][Full Text] [Related]
9. [Clinical study of double filtration plasmapheresis for treatment of refractory myasthenia gravis].
Huo JT; Long HL; Luo X; Xu JZ
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):355-7. PubMed ID: 17425991
[TBL] [Abstract][Full Text] [Related]
10. Antigen-specific immunoadsorption of anti-acetylcholine receptor antibodies from sera of patients with myastenia gravis.
Sun C; Meng F; Li Y; Jin Q; Li H; Li F
Artif Cells Blood Substit Immobil Biotechnol; 2010 Apr; 38(2):99-102. PubMed ID: 20196680
[TBL] [Abstract][Full Text] [Related]
11. [In-vitro and in-vivo studies on the selective immunoadsorption treatment of neurological diseases].
Heininger K
Schriftenr Neurol; 1993; 33():1-91. PubMed ID: 8327864
[No Abstract] [Full Text] [Related]
12. [The use of therapeutic apheresis in neurological diseases and comparison between plasma exchange and immunoadsorption].
Loschiavo C; Grecò M; Polo A; Del Colle R
G Ital Nefrol; 2015; 32(1):. PubMed ID: 25774587
[TBL] [Abstract][Full Text] [Related]
13. Immunoadsorption therapy for myasthenia gravis.
Shibuya N; Sato T; Osame M; Takegami T; Doi S; Kawanami S
J Neurol Neurosurg Psychiatry; 1994 May; 57(5):578-81. PubMed ID: 8201327
[TBL] [Abstract][Full Text] [Related]
14. Removal Characteristics of Immunoadsorption with the Tryptophan-Immobilized Column Using Conventional and Selective Plasma Separators in the Treatment of Myasthenia Gravis.
Ohkubo A; Okado T; Sakurasawa T; Maeda T; Itagaki A; Yamamoto H; Miyamoto S; Seshima H; Kurashima N; Mori T; Iimori S; Sohara E; Rai T; Uchida S; Naito S
Ther Apher Dial; 2019 Jun; 23(3):271-278. PubMed ID: 31025833
[TBL] [Abstract][Full Text] [Related]
15. Guillain-Barré syndrome treated by membrane plasma exchange and/or immunoadsorption.
Marn Pernat A; Buturović-Ponikvar J; Svigelj V; Ponikvar R
Ther Apher Dial; 2009 Aug; 13(4):310-3. PubMed ID: 19695065
[TBL] [Abstract][Full Text] [Related]
16. Clinical evaluation of a staphylococcal protein A immunoadsorption system in the treatment of myasthenia gravis patients.
Benny WB; Sutton DM; Oger J; Bril V; McAteer MJ; Rock G
Transfusion; 1999 Jul; 39(7):682-7. PubMed ID: 10413274
[TBL] [Abstract][Full Text] [Related]
17. [A case of myasthenia gravis with anti-MuSK antibodies showing a dramatic improvement with plasma exchange].
Suzuki H; Motomura M; Yoshimura T; Shiraishi H; Mitsui Y; Hasegawa T; Atsumi M; Kitaguchi M; Kusunoki S
Rinsho Shinkeigaku; 2005 Jul; 45(7):510-3. PubMed ID: 16119834
[TBL] [Abstract][Full Text] [Related]
18. Removal of antiacetylcholine receptor antibodies by protein-A immunoadsorption in myasthenia gravis.
Berta E; Confalonieri P; Simoncini O; Bernardi G; Busnach G; Mantegazza R; Cornelio F; Antozzi C
Int J Artif Organs; 1994 Nov; 17(11):603-8. PubMed ID: 7744521
[TBL] [Abstract][Full Text] [Related]
19. [Favorable results of plasmapheresis in severe myasthenia gravis].
Blom RJ; Kuks JB; Westerterp-Maas A; Oosterhuis HJ
Ned Tijdschr Geneeskd; 1997 Feb; 141(8):381-4. PubMed ID: 9157298
[TBL] [Abstract][Full Text] [Related]
20. Antigen-specific apheresis of human anti-acetylcholine receptor autoantibodies from myasthenia gravis patients' sera using Escherichia coli-expressed receptor domains.
Zisimopoulou P; Lagoumintzis G; Poulas K; Tzartos SJ
J Neuroimmunol; 2008 Aug; 200(1-2):133-41. PubMed ID: 18603305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]